 | | | | Two people in Ghana who later died tested positive for Marburg virus, a highly infectious disease similar to Ebola, the World Health Organization (WHO) said on Thursday. | | | | | | The following is a summary of some recent studies on COVID-19. They include research that warrants further study to corroborate the findings and that has yet to be certified by peer review. | | | | | | Bayer AG and BASF have won a new trial on $60 million in punitive damages they were ordered to pay a Missouri peach farmer who said dicamba, a herbicide they produced, drifted onto his orchard and harmed his crops. | | | | | | Drugmaker AbbVie Inc generates most of its sales in the United States, while shifting most of its profits overseas in order to avoid U.S. taxes, an interim report from the Senate Finance Committee said on Thursday. | | | | | | Less than a month after a hard-won deal was reached on a partial waiver of intellectual property rights for COVID-19 vaccines, a fresh battle may be looming at the World Trade Organization over extending the waiver to treatments and tests. | | | | | | Slovakia confirmed its first case of monkeypox, identified in a person in the 20-59 age group, who most likely contracted the virus abroad, Public Health Authority said on Thursday. | | | | | | Sweden is seeing an increase in COVID-19 cases and healthcare can expect an increase in pressure over the summer, the health minister said on Thursday. | | | | | | The European Medicines Agency (EMA) is open to using next generation COVID-19 vaccines that target older offshoots of the Omicron variant this fall, an official said on Thursday, amid a rise in cases due to new Omicron subvariants. | | | | | | Intercept Pharmaceuticals Inc will resubmit its application for approval of its therapy for a chronic liver disease to the U.S. Food and Drug Administration, two years after the regulator had declined to give the green light. | | | | | | Meridian Bioscience Inc will be acquired by SD Biosensor Inc and PE firm SJL Partners LLC in an all-cash $1.53-billion deal, the companies said on Thursday, accelerating the South Korean diagnostic firm's entry into the U.S. market. | | | | | |
